Completed from United Kingdom
The Masterclass Certificate in Medicinal Chemistry (Intermediate) perfectly aligned with my professional development plan. The modules on structure‑activity relationship (SAR) analysis and ADME profiling gave me the tools to redesign a lead compound for my current project, resulting in a 30 % increase in potency. The course materials were up‑to‑date, with clear case studies from recent FDA‑approved drugs. I especially appreciated the downloadable reaction‑scheme worksheets, which I could apply directly in the lab. Overall, the experience was highly professional and exceeded my expectations.
I loved the hands‑on vibe of this course. The video demos on virtual screening were super helpful, and I actually used the taught docking workflow to shortlist compounds for a summer internship. The PDFs were easy to follow, and the quizzes kept me on track. It felt like a real‑world bootcamp, and I left feeling confident I could talk about pharmacokinetic optimisation in any team meeting.
Wow – what an enthusiastic learning journey! The sections on lead optimisation were packed with practical tips, like how to calculate ligand efficiency and design bioisosteric replacements. I applied the taught fragment‑based design technique to my thesis and saw a clear improvement in the drug‑likeness score of my candidates. The interactive forums were lively, and the instructor’s feedback was always spot‑on. This course truly boosted my confidence and excitement for medicinal chemistry.
The course delivered a detailed exploration of medicinal chemistry principles. In particular, the module on metabolic stability provided step‑by‑step protocols for using in‑silico tools, which I later employed to predict the clearance of a novel series in my research group. The supplemental reading list, featuring recent journal articles, added depth to the theoretical concepts. The pacing was well‑structured, allowing me to absorb complex topics without feeling rushed. I am satisfied with the knowledge gained and would recommend it to peers.
